LMU University Hospital Munich: Real-time Data Visualization and Analysis in Clinical Ttrials with Imaging Endpoints

“mint Analytics expands your means of structured response assessment in mint Lesion™ by instantaneous visualization of the collected data, as a whole or per individual trial,” states PD Dr. Wolfgang Kunz, Head of Oncological Imaging and of the Oncological Study Center at the Ludwig-Maximilians-University Hospital Munich.

PD Dr. Kunz recounts how he and his team are able to keep a detailed overview of the status of their clinical trials and describes how sponsors and imaging CROs can benefit from mint Lesion™ and its add-on mint Analytics.

Read the Success Story here.

Clinical Trials Trial Monitoring Data Collection Data Analysis Clinical Trial Center mint Analytics

Related Resources

Related Resources

RECIST measurements of a patient with uveal melanoma and hepatic metastases

University Hospital Tuebingen: Study compares the Efficacy of SIRT and CS-PHP in Uveal Melanoma with Hepatic Metastasis

A study[1] conducted by researchers at University Hospital Tuebingen retrospectively compared the efficacy of two liver-targeted therapies,…

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

A picture of a person looking at a brain scan and the interface of mint Lesion™ on a computer

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…